**Core Concept**
Intracranial radiation therapy can lead to endocrine dysfunction due to damage to the hypothalamic-pituitary axis, resulting in hormone deficiencies. The pituitary gland is particularly vulnerable to radiation, leading to a cascade of downstream hormone deficiencies.

**Why the Correct Answer is Right**
The most common hormone deficiency seen after intracranial radiation therapy is growth hormone deficiency (GHD). This is because radiation can damage the pituitary gland, leading to reduced production of growth hormone-releasing hormone (GHRH) and growth hormone (GH). The hypothalamic-pituitary axis is responsible for regulating GH production, and damage to this axis can result in GHD. This deficiency can lead to growth failure, short stature, and other systemic effects.

**Why Each Wrong Option is Incorrect**
* **Option A:** Thyroid-stimulating hormone (TSH) deficiency is less common than GHD after intracranial radiation therapy.
* **Option B:** Adrenocorticotropic hormone (ACTH) deficiency can occur but is less frequent than GHD.
* **Option D:** Prolactin deficiency is not typically seen after intracranial radiation therapy.

**Clinical Pearl / High-Yield Fact**
It's essential to recognize that radiation-induced hormone deficiencies can be delayed, often manifesting years after treatment. Therefore, patients who have undergone intracranial radiation therapy should be monitored for endocrine dysfunction throughout their lives.

**Correct Answer: C. Growth hormone deficiency. Growth hormone deficiency is the most common hormone deficiency seen after intracranial radiation therapy.**